Interleukin-8 stimulates human immunodeficiency virus Type 1 replication and is a potential new target for antiretroviral therapy

Journal of Virology

Volumn 75, Issue 17, 2001, Pages 8195-8202

  Lane, B R ^a   Lore, K ^a   Bock, P J ^a   Andersson, J ^a   Coffey, M J ^a   Strieter, R M ^a   Markovitz, D M ^a  

^a 5220 MSRB III ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 8;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOID TISSUE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; GROWTH SUBSTANCES; HIV-1; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; LYMPHOID TISSUE; MACROPHAGES; MONOCYTES; PHENYLUREA COMPOUNDS; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 0034879050     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.17.8195-8202.2001     Document Type: Article

References (48)

1. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
2. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: Independence from G protein signaling and importance of coreceptor down-modulation
3. HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication
4. Concomitant in vivo production of 19 different cytokines in human tonsils
5. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy
6. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines
7. Blocking chemokine receptors
8. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
9. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
10. Inhibition of HIV type 1 BaL replication by MIP-1α, MIP-1β, and RANTES in macrophages
11. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
12. + T cells
13. RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages
14. Identification of a major co-receptor for primary isolates of HIV-1
15. Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects
16. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1α, MIP-1β and RANTES beta-chemokines
17. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
18. + cells is mediated by the chemokine receptor CC-CKR-5
19. Current evidence and future directions for targeting HIV entry: Therapeutic and prophylactic strategies
20. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
21. HIV infection and dementia
22. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
23. Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion
24. Toward an understanding of the correlates of protective immunity to HIV infection
25. Dichotomous effects of beta-chemokines on HIV replication in monocytes and monocyte-derived macrophages
26. + T cells: Role of signal transduction
27. Interleukin-8 as a macrophage-derived mediator of angiogenesis
28. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression
29. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
30. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression
31. Human immunodeficiency virus type 1 (HIV-1)-induced GRO-α production stimulates HIV-1 replication in macrophages and T lymphocytes
32. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes
33. + cell antiviral factor
34. Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication
35. Elevated serum levels of IL-8 in patients with HIV infection
36. Enhanced HIV-1 replication by chemokines constitutively expressed in secondary lymphoid tissues
37. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
38. Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-κB factors
39. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
40. Replication of HIV-1 in primary monocyte cultures
41. Chemokines and HIV replication
42. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4
43. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages
44. The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity
45. GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome
46. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration
47. Fully human anti-interleukin-8 monoclonal antibodies: Potential therapeutics for the treatment of inflammatory disease states
48. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines